Search

Page Title

Clinical Trial Finder

Back to the Study Details Page

Ask About Participating in This Study

ObservationalEnrolling

Study to evaluate the effects of CFTR modulators in infants and young children (BEGIN Part B), protocol number BEGIN-OB-19 Part B

The following information will be used to determine eligibility for this study. Fill out the form and click “Preview Message.” This will draft an email you can send directly to the Research Coordinator. Please note, this does not guarantee entry into this particular study.

* indicates required field

Personal Information

Add more details about who you are and how you would like to be contacted (e.g. phone, text, email).

Preview Message

(this will open in your email program)

ObservationalEnrolling

Study to evaluate the effects of CFTR modulators in infants and young children (BEGIN Part B), protocol number BEGIN-OB-19 Part B

This two-part observational study will look at the effects of CFTR modulators on growth in young children with CF. These drugs are intended to help CFTR protein function closer to normal.

  • Age:

    Less than 6 Years

  • Mutation(s):

    Mutation Requirement

  • FEV1% Predicted:

    No FEV1 Limit

  • Number of Visits:

    6

  • Length of Participation:

    2 years

CONTACT THE CLINICAL TRIAL NAVIGATOR

Get personalized assistance and answers to your clinical trial questions.

Learn More

Sign up for clinical trial alerts

Get email updates about clinical trials that matter to you.

Check the Drug Development Pipeline

We’re attacking CF from every angle. Learn about the status of CF drugs in development.

Learn More